India
· Delayed Price · Currency is INR Amrutanjan Health Care Statistics
Total Valuation
NSE:AMRUTANJAN has a market cap or net worth of INR 17.30 billion. The enterprise value is 15.02 billion.
| Market Cap | 17.30B |
| Enterprise Value | 15.02B |
Important Dates
The last earnings date was Friday, February 7, 2025.
| Earnings Date | Feb 7, 2025 |
| Ex-Dividend Date | Feb 18, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.55% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 12.98M |
Valuation Ratios
The trailing PE ratio is 35.07.
| PE Ratio | 35.07 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 5.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 30.47 |
| EV / Sales | 3.39 |
| EV / EBITDA | 26.09 |
| EV / EBIT | 29.01 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 230.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.51% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.00M |
| Profits Per Employee | 777,853 |
| Employee Count | 634 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.98% in the last 52 weeks. The beta is 0.79, so NSE:AMRUTANJAN's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -7.98% |
| 50-Day Moving Average | 684.31 |
| 200-Day Moving Average | 735.47 |
| Relative Strength Index (RSI) | 32.20 |
| Average Volume (20 Days) | 14,759 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AMRUTANJAN had revenue of INR 4.44 billion and earned 493.16 million in profits. Earnings per share was 17.04.
| Revenue | 4.44B |
| Gross Profit | 2.20B |
| Operating Income | 517.90M |
| Pretax Income | 678.83M |
| Net Income | 493.16M |
| EBITDA | 571.57M |
| EBIT | 517.90M |
| Earnings Per Share (EPS) | 17.04 |
Balance Sheet
The company has 2.29 billion in cash and 22.14 million in debt, giving a net cash position of 2.27 billion.
| Cash & Cash Equivalents | 2.29B |
| Total Debt | 22.14M |
| Net Cash | 2.27B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.98B |
| Book Value Per Share | 103.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.70%, with operating and profit margins of 11.67% and 11.12%.
| Gross Margin | 49.70% |
| Operating Margin | 11.67% |
| Pretax Margin | 15.30% |
| Profit Margin | 11.12% |
| EBITDA Margin | 12.88% |
| EBIT Margin | 11.67% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.60, which amounts to a dividend yield of 0.77%.
| Dividend Per Share | 4.60 |
| Dividend Yield | 0.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.55% |
| Shareholder Yield | 1.31% |
| Earnings Yield | 2.85% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 13, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Apr 13, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |